SenesTech Rings the Closing Bell at Nasdaq.

SenesTech, Inc. (Nasdaq: SNES), a developer of novel proprietary technologies for managing animal pest populations through fertility control, visited the Nasdaq MarketSite in Times Square to ring the closing bell on Friday, January 20, 2017.

 

In honor of the occasion, Dr. Loretta P. Mayer, Chair, CEO and co-founder of SenesTech, and Dr. Cheryl Dyer, President, Chief Research Officer and co-founder, rang the Closing Bell and were joined by family, friends, and supporters.

SenesTech has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach.

The Company’s first fertility control product, ContraPest®, will be marketed for use initially in controlling rat infestations. ContraPest’s novel technology and approach targets the reproductive capabilities of both sexes, inducing egg loss in female rodents and impairing sperm development in males. Using proprietary bait stations, ContraPest is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rodent communities. ContraPest is designed, formulated and dispensed to be safe for handlers and non-target species such as wildlife, livestock and pets, in a biodegradable product. In contrast, the historical approach to managing rodent pest populations, rodenticides, carries a high risk of environmental contamination and the poisoning of non-target animals, pets and children.

Senestech believes their non-lethal approach, targeting reproduction, is more humane, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods. There is currently no other non-lethal fertility control product approved by the Food and Drug Administration (FDA), or the Environmental Protection Agency (EPA), for the management of rodent populations.  They believe ContraPest® will establish a new paradigm in rodent control, resulting in improved performance in rodent control over rodenticides, without the negative environmental effects of rodenticides. 

For more information visit the SenesTech website at www.senestech.com.

“The listing of our shares on the Nasdaq was a tremendous milestone for SenesTech’s employees and early investors, and we are honored to ring the Nasdaq closing bell in celebration of this achievement,” said Dr. Loretta P. Mayer, Chair, CEO and co-founder of SenesTech.

Dr. Mayer continued, “SenesTech’s revolutionary technology for animal pest control changes the age-old kill and kill again practice by using cutting-edge science to get to the root cause of the problem: reproduction. Our solution aims to improve the quality of human life by reducing the chances of poisoned children and pets, reducing the spread of disease, getting more of the food we grow to our tables, and reducing infrastructure damage by rats.  We aim to do this by addressing the pest population in a more humane, sustainable, non lethal, effective and environmentally neutral, manner. We look forward to the opportunity of furthering our mission in the years to come.”

 

 

 

Note:  Photos are clips from video courtesy of NASDAQ. To see the video, visit FaceBook.com/AZBio

Posted in AZBio News.